Gestational diabetes

BobiHealth Launches Personalized Pregnancy Monitoring and Alert System Designed to Revolutionize Maternal Care and Support Health Care Equity

Retrieved on: 
Thursday, May 2, 2024
Baby, Maternity, Technology, Health, General Health, Women, Health Technology, Medical Devices, Apps, Applications, Artificial Intelligence, Mobile, Wireless, Consumer, Mortality, Pregnancy, Safety, Woman, Android, AI, CDC, Gestational hypertension, Heart, Infant, Black, White, Caregiver, Movement, Gestational diabetes, Multimedia, Death, Apple, Algorithm, Knowledge, Medical device

View the full release here: https://www.businesswire.com/news/home/20240502036712/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240502036712/en/
    The BobiHealth app, available for free on the Apple store through August 2024, offers expectant mothers and their caregivers detailed insights into maternal health.
  • Whether it's a potential concern or reassurance to continue monitoring, BobiHealth provides invaluable guidance driven by evidence-based science and AI algorithms.
  • Access to care, costs and potential racial bias in the health care system could contribute to these disparities.
  • Founded in 2023 with a mission to enhance the safety of pregnancy, BobiHealth is poised to revolutionize maternal healthcare with its intelligent monitoring and alerting solutions.

Mahmee Collaborates With Health Net to Provide Expecting and New Parents With Additional Doula and Wraparound Maternity Support

Retrieved on: 
Thursday, April 11, 2024
Managed Care, Other Health, General Health, Family, Consumer, Mental Health, Health Insurance, Parenting, Baby, Maternity, Nursing, Women, Practice Management, Health, Education, Mortality, IBCLC, Medi-Cal, BSN, Pregnancy, RNC, Parent, Infant, Consultant, Black, Health Net, Centene Corporation, Mental health, Pre-eclampsia, Lactation, Gestational diabetes

The program is designed to ensure new and expecting parents are seen, heard and cared for in the maternal health system.

Key Points: 
  • The program is designed to ensure new and expecting parents are seen, heard and cared for in the maternal health system.
  • "We are proud to be at the forefront of the changing landscape for maternal health.
  • "We're excited to expand our existing doula services to include Mahmee, which will provide specialized care teams to expecting and new parents throughout California,” said Vice President and Chief Health Equity Officer at Health Net, Dr. Pooja Mittal.
  • By offering these services, Mahmee and Health Net are empowering families to experience the life-saving benefits of proactive, ongoing wraparound support that they deserve.

Adhering to Asthma Medication is Safe for Pregnant Women with Asthma

Retrieved on: 
Friday, April 19, 2024
AAAAI, American Academy, NICU, Pregnancy, Risk, Woman, ICS, Place of birth, Doctor of Philosophy, Research, Patient, Asthma, Pre-eclampsia, Gestational diabetes, Mother, Multimedia, Placenta, Journal

MILWAUKEE , April 19, 2024 /PRNewswire-PRWeb/ -- Maintaining asthma medication and asthma control leads to safer perinatal outcomes for pregnant women according to new research published in The Journal of Allergy and Clinical Immunology: In Practice (JACI: In Practice), an official journal of the American Academy of Allergy, Asthma & Immunology (AAAAI).

Key Points: 
  • "We showed the importance of continuing asthma medication during pregnancy to improve pregnancy, maternal and neonatal outcomes.
  • According to the research, asthma affects 5-13% of pregnant women with many women requiring daily pharmacotherapy to achieve asthma control, however, adherence to medication often decreases during pregnancy.
  • To understand the association between the use of asthma medication on asthma exacerbation and maternal and neonatal outcomes, researchers used linked population-based administrative databases from Alberta, Canada, spanning from 2012 to 2018 to categorize pregnant women with asthma based on their asthma medication use one year prior to pregnancy.
  • The study found that, 38% - 60% of pregnant women discontinued either rescue or maintenance asthma medication with minimal adherence to maintenance medication, although the reason for discontinuation was unknown.

It’s time for a heart-to-heart about women’s cardiovascular health, unique risk factors and symptoms

Retrieved on: 
Sunday, February 11, 2024
Chest pain, Breast cancer, Chronic kidney disease, Neck, Hypertension, Woman, Autoimmune disease, Blood, Friends, Cardiovascular disease, Gestational diabetes, News, Female, Endometriosis, Herbal cigarette, Nausea, Fertility, Complications of pregnancy, Pregnancy, Life, Risk, Back pain, Polycystic ovary syndrome, Health, Menopause, Fatigue, Death, Mother, Family, Eating, Tobacco, Disease, Indigestion, Heart, Jaw, Depression, Dietary supplement

Cardiovascular disease — also called heart disease — is a condition affecting the heart and blood vessels, and is the leading cause of death among women worldwide.

Key Points: 
  • Cardiovascular disease — also called heart disease — is a condition affecting the heart and blood vessels, and is the leading cause of death among women worldwide.
  • In fact, a women dies of heart disease every 20 minutes in Canada.
  • Although cardiovascular disease is often considered a disease of men, women are more likely to die from a heart attack when compared with men.

Women’s hearts are different

  • From the outside, women’s hearts may look the same as men’s, but there are important differences.
  • Specifically, women experience unique events over the course of their lifespan which may impact their cardiovascular health.
  • Pregnancy complications, such as hypertensive disorders of pregnancy and gestational diabetes, can also play a role in cardiovascular health.

Heart attack symptoms

  • Early heart attack symptoms are missed in up to 78 per cent of women, in part related to the fact that women may present with different symptoms than men.
  • An awareness of the differences in heart attack symptoms may lead to improved recognition and timely care for women.

Reducing heart risks

  • There are many steps that you can take to reduce your risk of heart disease.
  • Living free from commercial tobacco and vaping, reducing alcohol intake and managing stress are also key ways to reduce your risk.

Wear red and learn more

  • On Feb. 13, we invite you to celebrate Wear Red Canada to raise awareness for women’s cardiovascular health, hosted by the Canadian Women’s Heart Health Alliance and the Canadian Women’s Heart Health Centre.
  • Attend free presentations and webinars by Canadian experts, join the Wear Red Canada Movement Challenge and take part in local events.


Nabilah Gulamhusein has received funding from the Canadian Institutes of Health Research through the Canada Graduate Scholarship - Master’s. Sandi Dumanski receives funding from the Canadian Fertility and Andrology Society and the Kidney Foundation.

MemorialCare Launches New Women's Heart Center and Recruits Nissi Suppogu, M.D. as Medical Director - Creating Sub-Specialized Women's Heart Health Center in Community

Retrieved on: 
Thursday, February 1, 2024
Cardiology, Anxiety, Microangiopathy, Hypertension, Long Beach Medical Center, Family, Artery, Obesity, Heart, Chronic pain, Cardiovascular disease, Gestational diabetes, Research, Exercise, Patient, Splenic infarction, Diagnosis, Scar, Friends, Autoimmune disease, Chest pain, Catheter, Depression, Pregnancy, Neck, Physician, Vasospasm, Diabetes, Dizziness, Education, Risk, Menopause, Smoking, Blood, Rest, Health, Place of birth, Fatigue, Human, Rehabilitation

FOUNTAIN VALLEY, Calif., Feb. 1, 2024 /PRNewswire/ -- MemorialCare, a prominent nonprofit Southern California integrated health system, has announced the launch of the Women's Heart Center at the MemorialCare Heart & Vascular Institute – a specialized center dedicated solely to expertise in education, prevention, early diagnosis, and timely management of women-specific cardiac presentations across their lifespan. The Women's Heart Center's first site will be in conjunction with Long Beach Medical Center and MemorialCare Medical Group, with future plans to expand to additional MemorialCare sites in Orange County.

Key Points: 
  • The Women's Heart Center's first site will be in conjunction with Long Beach Medical Center and MemorialCare Medical Group , with future plans to expand to additional MemorialCare sites in Orange County.
  • To lead a dynamic and distinctive program such as this, MemorialCare has recruited and appointed Nissi Suppogu, M.D.
  • as the medical director of the Women's Heart Center.
  • Dr. Suppogu is fellowship trained, meaning she has two years of additional sub-specialty training and education in women's heart health.

Annals of Family Medicine: The risk of death during or shortly after childbirth is higher for people in the US than in other developed countries.

Retrieved on: 
Thursday, January 25, 2024
Mortality, Death, Patient, Family medicine, Research, Annals of Family Medicine, Health, Multimedia, Society, American Academy, Federally Qualified Health Center, Gestational diabetes, Risk, Pregnancy, FQHC, Quality, Prenatal development, White, Teacher, Physician, College, QI, Depression, Nursing

PROVIDENCE, R.I., Jan. 25, 2024 /PRNewswire/ -- In a new article published in Annals of Family Medicine, "A Mixed Methods Evaluation of a Quality Improvement Model to Optimize Perinatal and Primary Care in the Community Health Setting," researchers assessed a quality improvement learning collaborative's (QILC) intervention to link high-risk prenatal patients with primary care. The aims of the study were twofold: to measure the impact of the intervention on postpartum and primary care utilization for high-risk prenatal patients and to explore the Federally Qualified Health Center (FQHC) participants' experiences of working with a QI collaborative.

Key Points: 
  • Using information from patient's health records, 19 clinics within the six participating FQHCs identified high-risk prenatal patients who delivered between January and June 2021.
  • The QI intervention implemented a patient registry and conducted direct patient outreach for six months after delivery to connect patients to primary care.
  • At the conclusion of the intervention, all six FQHCs had successfully implemented processes for coordinating their maternal and primary care.
  • Complete editorial content and interactive discussion groups for each published article can be accessed for free on the journal's website, www.AnnFamMed.org .

The American Diabetes Association Releases the Standards of Care in Diabetes--2024

Retrieved on: 
Monday, December 11, 2023
Epidemiology, AID, Standard of care, Infection, PPC, Gestational diabetes, Diagnosis, CVD, Disability, Doctor of Philosophy, Mental health, Abridgement, Prediabetes, Diabetes, Knowledge, Webcast, NAFLD, RSV, Endocrinology, Fatty liver disease, Kidney disease, Cardiovascular disease, Fracture, Moyamoya disease, Society, Physician, Public, Hypoglycemia, Waist, Practitioner, PAD, Risk, Pharmacist, GIP, C-peptide, Artificial intelligence, Immunization, Conditional sentence, Section 4, Body mass index, Himawari (satellites), Classification, The Obesity Society, American Diabetes Association, Vaccine, Obesity, American College, Heart failure, COVID-19, Dietary supplement, Nursing, Landscape maintenance, Pharmaceutical industry, Medical device, Dentistry, MD

ARLINGTON, Va., Dec. 11, 2023  /PRNewswire/ -- Today, the American Diabetes Association® (ADA) released the Standards of Care in Diabetes—2024 (Standards of Care), a set of comprehensive and evidence-based guidelines for managing type 1, type 2, gestational diabetes, and prediabetes based on the latest scientific research and clinical trials. It includes strategies for diagnosing and treating diabetes in both youth and adults, methods to prevent or delay type 2 diabetes and its associated comorbidities like cardiovascular disease (CVD) and obesity, and therapeutic approaches aimed at minimizing complications and enhancing health outcomes.

Key Points: 
  • "The latest ADA guidelines present pivotal updates for health care professionals, ensuring comprehensive, evidence-based care for diabetes management.
  • "The ADA's Standards of Care ensures health care professionals, especially our primary care workforce, provide the best possible care to those living with diabetes."
  • The Standards of Care are critical to ensuring the improved treatment of diabetes, a chronic disease that requires continuous care through a well-informed and coordinated health care team.
  • Today, the Standards of Care in Diabetes—2024 is available online and is published as a supplement to the January 2024 issue of Diabetes Care® .

Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici

Retrieved on: 
Wednesday, November 15, 2023
Meal, Novo Nordisk, T1D, Prevalence, Therapy, Insulin, Weight loss, Abdominal pain, Eating, Disease, International Diabetes Federation, IDF, Fatigue, Autoantibody, Pancreas, Random glucose test, Finerenone, Urination, Health, Eli Lilly, Eli Lilly and Company, Diabetes, Gestational diabetes, Hunger, Hyperglycemia, Xerostomia, Type 1, Glycated hemoglobin, Glucose, LAS, Overalls, Vertex Pharmaceuticals, Type 2 diabetes, Hypoglycemia, Pharmaceutical industry, Dietary supplement, Bayer

LAS VEGAS, Nov. 15, 2023 /PRNewswire/ -- DelveInsight's Type 1 Diabetes Market Insights report includes a comprehensive understanding of current treatment practices, type 1 diabetes emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].

Key Points: 
  • According to the International Diabetes Federation (IDF), Type 1 diabetes may affect anybody at any age, although it impacts children and adolescents the most commonly.
  • Over 1 million children and adolescents under the age of 20 have type 1 diabetes.
  • Diabetes is medically categorized into three primary types, with Type 1 diabetes, Type 2 diabetes, and gestational diabetes being the main classifications.
  • To know more about type 1 diabetes treatment, visit @ Type 1 Diabetes Treatment Drugs

Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici

Retrieved on: 
Wednesday, November 15, 2023
Meal, Novo Nordisk, T1D, Prevalence, Therapy, Insulin, Weight loss, Abdominal pain, Eating, Disease, International Diabetes Federation, IDF, Fatigue, Autoantibody, Pancreas, Random glucose test, Finerenone, Urination, Health, Eli Lilly, Eli Lilly and Company, Diabetes, Gestational diabetes, Hunger, Hyperglycemia, Xerostomia, Type 1, Glycated hemoglobin, Glucose, LAS, Overalls, Vertex Pharmaceuticals, Type 2 diabetes, Hypoglycemia, Pharmaceutical industry, Dietary supplement, Bayer

LAS VEGAS, Nov. 15, 2023 /PRNewswire/ -- DelveInsight's Type 1 Diabetes Market Insights report includes a comprehensive understanding of current treatment practices, type 1 diabetes emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].

Key Points: 
  • According to the International Diabetes Federation (IDF), Type 1 diabetes may affect anybody at any age, although it impacts children and adolescents the most commonly.
  • Over 1 million children and adolescents under the age of 20 have type 1 diabetes.
  • Diabetes is medically categorized into three primary types, with Type 1 diabetes, Type 2 diabetes, and gestational diabetes being the main classifications.
  • To know more about type 1 diabetes treatment, visit @ Type 1 Diabetes Treatment Drugs

Food For Health partners with iCare to address hypertension, type 2 diabetes

Retrieved on: 
Tuesday, November 14, 2023
Meal, World Diabetes Day, Eastern Health Alliance, Hypertension, Medicaid, Quality, Food, Disability, Cardiovascular disease, Patient, Type 2 diabetes, FFH, Pre-eclampsia, Food and Health Bureau, Health, Friends, Gestational diabetes, Partnership, Eçara, Medicare, Family, Humana, Diabetes, Quality of life, Education, Pharmaceutical industry, Dietary supplement, Nursing

MILWAUKEE, Nov. 14, 2023 /PRNewswire/ -- Managing hypertension and type 2 diabetes is challenging under any circumstance, but increasingly so for residents of underserved communities.

Key Points: 
  • To address this challenge, Food For Health is partnering with Humana-subsidiary Independent Care Health Plan, or iCare, to provide Medically Tailored Meal programming for Medicaid members who are patients of Milwaukee Health Services Clinics.
  • Today's announcement coincides with World Diabetes Day, a global awareness campaign around the growing concerns of the escalating health threats of diabetes.
  • "Our patient-centric program is proven to reverse, manage and prevent diet-related disease including type 2 diabetes, hypertension, cardiovascular disease, and maternal health concerns, specifically gestational diabetes and preeclampsia."
  • iCare and Milwaukee Health Services' MLK Heritage Health Center identify members who meet the enrollment criteria.